Published in Antimicrob Agents Chemother on August 01, 1983
Microbiological and clinical aspects of infection associated with Stenotrophomonas maltophilia. Clin Microbiol Rev (1998) 5.33
Biochemical properties of beta-lactamase produced by Flavobacterium odoratum. Antimicrob Agents Chemother (1985) 3.62
Human infections associated with Bordetella bronchiseptica. Clin Microbiol Rev (1991) 2.91
Clinical and microbiological characteristics of Flavobacterium indologenes infections associated with indwelling devices. J Clin Microbiol (1996) 2.19
Increasing incidence of nosocomial Chryseobacterium indologenes infections in Taiwan. Eur J Clin Microbiol Infect Dis (1997) 1.75
In vitro activities of quinolones, beta-lactams, tobramycin, and trimethoprim-sulfamethoxazole against nonfermentative gram-negative bacilli. Antimicrob Agents Chemother (1996) 1.45
In vitro activities of aztreonam, piperacillin, and ticarcillin combined with amikacin against amikacin-resistant Pseudomonas aeruginosa and P. cepacia isolates from children with cystic fibrosis. Antimicrob Agents Chemother (1984) 1.41
Antimicrobial susceptibility of flavobacteria as determined by agar dilution and disk diffusion methods. Antimicrob Agents Chemother (1997) 1.34
Antimicrobial susceptibility of Bordetella avium and Bordetella bronchiseptica isolates. Antimicrob Agents Chemother (1989) 1.30
Septicemia caused by Sphingobacterium multivorum. J Clin Microbiol (1987) 1.22
Penetration of aztreonam into cerebrospinal fluid of patients with and without inflamed meninges. Antimicrob Agents Chemother (1984) 1.03
Purification and properties of inducible penicillin beta-lactamase isolated from Alcaligenes faecalis. Antimicrob Agents Chemother (1985) 0.93
Comparison of susceptibility of gentamicin-resistant and -susceptible "Acinetobacter anitratus" to 15 alternative antibiotics. Antimicrob Agents Chemother (1986) 0.93
Comparison of Etest and agar dilution method for antimicrobial susceptibility testing of Flavobacterium isolates. J Clin Microbiol (1997) 0.92
Pseudomonas sp. group Ve-2 bacterial peritonitis in a patient on continuous ambulatory peritoneal dialysis. J Clin Microbiol (1987) 0.91
In vitro activity of carumonam (Ro 17-2301; AMA-1080) versus enteropathogenic and nonfermentative gram-negative rods and Legionella pneumophila. Antimicrob Agents Chemother (1988) 0.79
[Calculated initial chemotherapy in mechanically-ventilated postoperative patients with peritonitis, sepsis and pneumonia]. Infection (1986) 0.75
Comparative activities of 13 beta-lactam antibiotics. Antimicrob Agents Chemother (1982) 4.13
In vitro activity of azthreonam, a monobactam antibiotic. Antimicrob Agents Chemother (1982) 2.70
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.06
In vitro comparison of third-generation cephalosporins, piperacillin, dibekacin, and other aminoglycosides against aerobic bacteria. Antimicrob Agents Chemother (1981) 1.29
Comparative in vitro activities of N-formimidoyl thienamycin and moxalactam against nonfermentative aerobic gram-negative rods. Antimicrob Agents Chemother (1982) 1.22
beta-Lactam nomenclature. J Antimicrob Chemother (1982) 1.07
Increasing prevalence of multidrug-resistant Streptococcus pneumoniae in the United States. N Engl J Med (2000) 8.05
Syndrome of Rochalimaea henselae adenitis suggesting cat scratch disease. Ann Intern Med (1993) 4.88
Practical disk diffusion method for detection of inducible clindamycin resistance in Staphylococcus aureus and coagulase-negative staphylococci. J Clin Microbiol (2003) 4.31
National collaborative study of the prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1988) 3.40
Pneumonia due to Chlamydia trachomatis in the immunocompromised (nude) mouse. J Infect Dis (1981) 3.19
Management of community-acquired pneumonia in the era of pneumococcal resistance: a report from the Drug-Resistant Streptococcus pneumoniae Therapeutic Working Group. Arch Intern Med (2000) 3.09
Rapid penicillinase paper strip test for detection of beta-lactamase-producing Haemophilus influenzae and Neisseria gonorrhoeae. Antimicrob Agents Chemother (1977) 3.02
Methicillin-resistant Staphylococcus aureus as a community organism. Clin Infect Dis (1995) 2.80
Prevalence of antimicrobial resistance among clinical isolates of Haemophilus influenzae: a collaborative study. Diagn Microbiol Infect Dis (1986) 2.77
Simplified medium for ampicillin susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1975) 2.71
Comparative evaluation of the Limulus assay and the direct Gram stain for detection of significant bacteriuria. Am J Clin Pathol (1975) 2.69
Resistance to polyene antibiotics and correlated sterol changes in two isolates of Candida tropicalis from a patient with an amphotericin B-resistant funguria. J Infect Dis (1974) 2.61
Mortality from invasive pneumococcal pneumonia in the era of antibiotic resistance, 1995-1997. Am J Public Health (2000) 2.57
Factors governing adherence of Candida species to plastic surfaces. Infect Immun (1985) 2.57
Macrolide resistance among invasive Streptococcus pneumoniae isolates. JAMA (2001) 2.40
Serogroup-specific epidemiology of Streptococcus pneumoniae: associations with age, sex, and geography in 7,000 episodes of invasive disease. Clin Infect Dis (1996) 2.29
Coccidioidomycosis. Part I. Am Rev Respir Dis (1978) 2.25
Treatment of disseminated mycotic infectioons. A new approach to amphotericin B therapy. Am J Med (1968) 2.18
Rapid, simple bioassay for 5-fluorocytosine in the presence of amphotericin B. Antimicrob Agents Chemother (1975) 2.17
Disk diffusion susceptibility testing of Haemophilus influenzae using haemophilus test medium. Eur J Clin Microbiol Infect Dis (1990) 2.12
Preparation, sensitivity, and specificity of Limulus lysate for endotoxin assay. Appl Microbiol (1973) 2.09
In vitro activities of moxalactam and cefotaxime against aerobic gram-negative bacilli. Antimicrob Agents Chemother (1980) 2.06
Cloning and expression of Legionella pneumophila antigens in Escherichia coli. Infect Immun (1984) 2.03
Detection of Tn917-like sequences within a Tn916-like conjugative transposon (Tn3872) in erythromycin-resistant isolates of Streptococcus pneumoniae. Antimicrob Agents Chemother (1998) 2.03
Adherence and penetration of vascular endothelium by Candida yeasts. Infect Immun (1983) 2.02
Coccidioidomycosis: factors affecting the host-parasite interaction. J Infect Dis (1983) 2.02
Development of amphotericin B-resistant Candida tropicalis in a patient with defective leukocyte function. Am J Med Sci (1979) 2.02
Clinical and molecular epidemiology of vancomycin-resistant Enterococcus faecium during its emergence in a city in southern Texas. Clin Infect Dis (1995) 1.97
Reappraisal of the antimicrobial susceptibilities of Chryseobacterium and Flavobacterium species and methods for reliable susceptibility testing. Antimicrob Agents Chemother (1997) 1.95
Xenorhabdus luminescens (DNA hybridization group 5) from human clinical specimens. J Clin Microbiol (1989) 1.88
Typhoid fever. An epidemic with remarkably few clinical signs and symptoms. Arch Intern Med (1984) 1.88
Failure of ceftazidime-amikacin therapy for bacteremia and meningitis due to Klebsiella pneumoniae producing an extended-spectrum beta-lactamase. Antimicrob Agents Chemother (1990) 1.87
Coccidioidomycosis. Part II. Am Rev Respir Dis (1978) 1.83
Excretion pathways of amphotericin B. J Infect Dis (1979) 1.82
Outbreak of central-nervous-system toxoplasmosis in western Europe and North America. Lancet (1983) 1.80
Amphotericin B in liposomes: a novel therapy for histoplasmosis. Am Rev Respir Dis (1982) 1.77
Sensitive bioassay for ketoconazole in serum and cerebrospinal fluid. Antimicrob Agents Chemother (1981) 1.77
Methods for improved detection of oxacillin resistance in coagulase-negative staphylococci: results of a multicenter study. J Clin Microbiol (1999) 1.76
In vitro activity of LY146032 (daptomycin) against selected aerobic bacteria. Eur J Clin Microbiol (1987) 1.76
In vitro antimicrobial susceptibility testing of Borrelia burgdorferi: a microdilution MIC method and time-kill studies. J Clin Microbiol (1992) 1.75
Identification of coagulase-negative staphylococci with the API STAPH-IDENT system. J Clin Microbiol (1983) 1.70
Quantitative susceptibility test methods in major United States medical centers. Antimicrob Agents Chemother (1981) 1.70
Passive immunization in murine cryptococcosis. Sabouraudia (1981) 1.59
In-vitro susceptibility of Streptococcus pneumoniae to the d- and l-isomers of ofloxacin: interpretive criteria and quality control limits. J Antimicrob Chemother (1996) 1.59
Comparison of moxalactam (LY127935) and cefotaxime against anaerobic bacteria. Antimicrob Agents Chemother (1980) 1.59
Combination therapy of experimental histoplasmosis and cryptococcosis with amphotericin B and ketoconazole. Rev Infect Dis (1981) 1.58
In vitro antifungal susceptibility testing and measurement of levels of antifungal agents in body fluids. Rev Infect Dis (1987) 1.58
Fungal peritonitis in patients on continuous ambulatory peritoneal dialysis. Ann Intern Med (1983) 1.56
The clinical spectrum of endemic psittacosis. Arch Intern Med (1967) 1.56
Incorporation of tritiated thymidine by leprosy bacilli in cultures of human lepromatous macrophages. J Infect Dis (1972) 1.54
Use of Mueller-Hinton agar to determine novobiocin susceptibility of coagulase-negative staphylococci. J Clin Microbiol (1982) 1.54
Quality control limits for disk diffusion and broth microdilution susceptibility tests with Haemophilus test medium. Diagn Microbiol Infect Dis (1992) 1.53
Comparison of automated and rapid manual methods for the same-day identification of Enterobacteriaceae. Am J Clin Pathol (1983) 1.53
Host defense in cryptococcosis. II. Cryptococcosis in the nude mouse. Cell Immunol (1978) 1.52
Rapid detection of contaminated intravenous fluids using the Limulus in vitro endotoxin assay. Appl Microbiol (1973) 1.52
Simplified bioassay method for measurement of flucytosine or ketoconazole. J Clin Microbiol (1985) 1.52
Rapid detection of gram-negative bacteriuria by use of the Limulus endotoxin assay. Appl Microbiol (1973) 1.51
Vancomycin MICs for methicillin-resistant Staphylococcus aureus isolates differ based upon the susceptibility test method used. Antimicrob Agents Chemother (2008) 1.51
Rapid diagnosis of gram-negative bacterial meningitis by the Limulus endotoxin assay. J Clin Microbiol (1978) 1.51
The continuous bacteremia of lepromatous leprosy. N Engl J Med (1972) 1.49
Rapid recognition of methicillin-resistant Staphylococcus aureus by use of automated test systems. J Clin Microbiol (1984) 1.47
Variability of clarithromycin and erythromycin susceptibility tests with Haemophilus influenzae in four different broth media and correlation with the standard disk diffusion test. J Clin Microbiol (1988) 1.44
In vitro activity of the new macrolide antibiotic roxithromycin (RU 28965) against clinical isolates of Haemophilus influenzae. Antimicrob Agents Chemother (1986) 1.40
Microdilution technique for antimicrobial susceptibility testing of Haemophilus influenzae. Antimicrob Agents Chemother (1975) 1.37
Host defense in cryptococcosis. III. Protection of nude mice by thymus transplantation. J Infect Dis (1979) 1.36
Evaluation of the automicrobic system gram-positive identification card for species identification of coagulase-negative staphylococci. J Clin Microbiol (1983) 1.35
High-dose ketoconazole for treatment of fungal infections of the central nervous system. Ann Intern Med (1983) 1.33
Double blind fluid therapy evaluation in pediatric cholera. Pediatrics (1969) 1.33
Histoplasma capsulatum infection in nude mice. Infect Immun (1978) 1.31
Association of antibiotic utilization measures and control of multiple-drug resistance in Klebsiella pneumoniae. Infect Control Hosp Epidemiol (2000) 1.28
Bacterial interference in the therapy of recurrent staphylococcal infections. Multiple abscesses due to the implantation of the 502A strain of staphylococcus. N Engl J Med (1966) 1.26
Relationship of progesterone- and estradiol-binding proteins in Coccidioides immitis to coccidioidal dissemination in pregnancy. Infect Immun (1983) 1.25
Comparison of two automated instrument systems for rapid susceptibility testing of gram-negative bacilli. J Clin Microbiol (1983) 1.25
Molecular characterization and multilaboratory evaluation of Enterococcus faecalis ATCC 51299 for quality control of screening tests for vancomycin and high-level aminoglycoside resistance in enterococci. J Clin Microbiol (1995) 1.25
In vitro activity of vancomycin against the spirochete Borrelia burgdorferi. Antimicrob Agents Chemother (1993) 1.23
Human sex hormones stimulate the growth and maturation of Coccidioides immitis. Infect Immun (1981) 1.21
RP 59500, a new streptogramin highly active against recent isolates of North American staphylococci. Diagn Microbiol Infect Dis (1993) 1.20
Rapid detection of bacterial endotoxins in drinking water and renovated wastewater. Appl Environ Microbiol (1976) 1.20
Immunologic studies of disseminated infection with Aspergillus fumigatus in the nude mouse. J Infect Dis (1981) 1.20
Comparative activities of selected beta-lactam antibiotics against Haemophilus influenzae. Antimicrob Agents Chemother (1978) 1.20
Toxoplasmosis presenting as panhypopituitarism in a patient with the acquired immune deficiency syndrome. Am J Med (1984) 1.19
Intracellular and extracellular defenses of human phagocytes against Blastomyces dermatitidis conidia and yeasts. J Lab Clin Med (1985) 1.15
Evaluation of broth disk elution methods for susceptibility testing of anaerobic bacteria with the newer beta-lactam antibiotics. J Clin Microbiol (1986) 1.15
Characterization of Staphylococcus aureus in a pediatric burn unit. Appl Microbiol (1973) 1.14
Activities of newer beta-lactam antibiotics against ampicillin, chloramphenicol, or multiply-resistant Haemophilus influenzae. Diagn Microbiol Infect Dis (1984) 1.13
Reconstitution of the vitamin D-responsive osteocalcin transcription unit in Saccharomyces cerevisiae. Mol Cell Biol (1989) 1.13
Demonstration, by immunoelectronmicroscopy, of a cell wall antigen in Trichosporon beigelii that cross-reacts with Cryptococcus neoformans capsular polysaccharide. J Infect Dis (1988) 1.13
Treatment of experimental murine aspergillosis with BAY n7133. J Infect Dis (1983) 1.12
Varied presentations and responses to treatment of infections caused by Mycobacterium haemophilum in patients with AIDS. Clin Infect Dis (1992) 1.12
Serotypes of Cryptococcus neoformans in patients with AIDS. J Infect Dis (1986) 1.11
Electron-microscopic observations of the Coccidioides immitis parasitic cycle in vivo. J Med Vet Mycol (1986) 1.11
Influence of fungal surface components on the interaction of Coccidioides immitis with polymorphonuclear neutrophils. J Infect Dis (1986) 1.10
Experimental chemotherapy of histoplasmosis in nude mice. Am Rev Respir Dis (1979) 1.08
A Legionella-specific DNA probe detects organisms in lung tissue homogenates from intranasally inoculated mice. Isr J Med Sci (1986) 1.07
Measurement of bound and free endotoxin by the Limulus assay. Proc Soc Exp Biol Med (1974) 1.06